Protein thiol modification by 15-deoxy-Δ12,14- prostaglandin J2 addition in mesangial cells: Role in the inhibition of pro-inflammatory genes

Molecular Pharmacology

Volumn 66, Issue 5, 2004, Pages 1349-1358

  Sánchez Gómez, Francisco J ^a   Cernuda Morollón, Eva ^a   Stamatakis, Konstantinos ^a   Pérez Sala, Dolores ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; GENE EXPRESSION; INCUBATION TIME; INFLAMMATION; INHIBITION KINETICS; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; RAT; TWO DIMENSIONAL ELECTROPHORESIS;

ANIMALS; BIOTINYLATION; CELL NUCLEUS; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOPENTANES; CYTOSOL; GENE SILENCING; GLOMERULAR MESANGIUM; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; ISOENZYMES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PROSTAGLANDIN D2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEINS; RATS; SULFHYDRYL COMPOUNDS; TRANSFECTION;

EID: 6944250291     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.002824     Document Type: Article

References (40)

1. 2. Biochemistry 29:3760-3765.
2. 2 in activated murine macrophages. Mol Cell Biol 20:1692-1698.
3. 2 inhibition of NF-κB DNA binding through covalent modification of the p50 subunit. J BM Chem 276:35530-35536.
4. Cernuda-Morollón E, Rodríguez-Pascual F, Klatt P, Lamas S, and Pérez-Sala D (2002) PPAR agonists amplify iNOS expression while inhibiting NF-κB: implications for mesangial cell activation by cytokines. J Am Soc Nephrol 13:2223-2231.
5. 2 ameliorates ischemic acute renal failure. Cardiovasc Res 61:630-643.
6. 2, involves inhibition of the upstream Janus kinase/STAT1 signaling pathway. J Immunol 171:979-988.
7. 2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms. J Immunol 170:4578-4592.
8. 2 against the multiple organ failure caused by endotoxin. Crit Care Med 32:826-831.
9. 2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut. Br J Pharmacol 140:366-376.
10. 2 attenuates the development of acute and chronic inflammation. Mol Pharmacol 61:997-1007.
11. Fahmi H, Di Battista JA, Pelletier JP, Mineau F, Ranger P, and Martel-Pelletier J (2001) Peroxisome proliferator-activated receptor gamma activators inhibit interleukin-1beta-induced nitric oxide and matrix metalloproteinase 13 production in human chondrocytes. Arthritis Rheum 44:595-607.
12. 2 is a ligand for the adipocyte determination factor PPAK gamma. Cell 83:803-812.
13. Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, and Willoughby DA (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 3:698-701.
14. He TC, Chan TA, Vogelstein B, and Kinzler KW (1999) PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335-345.
15. Hollinshead M, Sanderson J, and Vaux DJ (1997) Anti-biotin antibodies offer superior organelle-specific labeling of mitochondria over avidin or streptavidin. J Histochem Cytochem 45:1053-1057.
16. 2 and 2-cyclopenten-1-one: role of the heat shock response. Mol Pharmacol 64:85-93.
17. 2 reduce restenosis after balloon angioplasty in rats: role of NF-kappaB. FEBS Lett 553:21-27.
18. 2. Mol Cell Biol 24:36-45.
19. Kumar A, Piedrafita F, and Reynolds W (2004) Peroxisome proliferator-activated receptor γ ligands regulate myeloperoxidase expression in macrophages by an estrogen-dependent mechanism involving the -463GA promoter polymorphism. J Biol Chem 279:8300-8315.
20. 2 and aminoguanidine. A role for peroxisome proliferator-activated receptor γ activation and iNOS expression. J Biol Chem 274:18702-18708.
21. Lee G, Elwood F, McNally J, Weiszmann J, Lindstrom M, Amaral K, Nakamura M, Miao S, Cao P, Learned RM, et al. (2002) T0070907, a selective ligand for peroxisome proliferator-activated receptor γ, functions as an antagonist of biochemical and cellular activities. J Biol Chem 277:19649-19657.
22. Levonen AL, Landar A, Ramachandran A, Ceaser EK, Dickinson DA, Zanoni G, Morrow JD, and Darley-Usmar VM (2004) Cellular mechanisms of redox cell signaling: the role of cysteine modification in controlling antioxidant defenses in response to electrophilic lipid oxidation products. Biochem J 378:373-382.
23. 2 synthase and inducible nitric oxide synthase in cardiac myocytes. Hypertension 42:844-850.
24. Mené P (1996) Physiology and pathophysiology of the mesangial cell. Nefrología 16:8-13.
25. Moos PJ, Edes K, Cassidy P, Massuda E, and Fitzpatrick FA (2003) Electrophilic prostaglandins and lipid aldehydes repress redox- sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J Biol Chem 278:745-750.
26. 2 binds to and activates H-Ras. Proc Natl Acad Sci USA 100:4772-4777.
27. 2 in MCF7 breast cancer cells. Biochemistry 42:5429-5437.
28. 2. J Biol Chem 278:51251-51260.
29. 2 inhibition of mesangial cell iNOS expression. Clin Immunol 98:337-345.
30. Ricote M, Li AC, Willson TM, Kelly CJ, and Glass CK (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature (Lond) 391:79-82.
31. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, and Santoro MG (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature (Lond) 403:103-108.
32. Rovin BH, Lu L, and Cosio A (2001) Cyclopentenone prostaglandins inhibit cytokine-induced NF-kappaB activation and chemokine production by human mesangial cells. J Am Soc Nephrol 12:1659-1667.
33. Rzymkiewicz D, Leingang K, Baird N, and Morrison A (1994) Regulation of prostaglandin endoperoxide synthase gene expression in rat mesangial cells by interleukin-1 beta. Am J Physiol 266:F39-F45.
34. Satriano J, Banas B, Luckow B, Nelson P, and Schlondorff D (1997) Regulation of RANTES and ICAM-1 expression in murine mesangial cells. J Am Soc Nephrol 8:596-603.
35. Saura M, López S, Rodríguez-Puyol M, Rodríguez-Puyol D, and Lamas S (1995) Regulation of inducible nitric oxide synthase expression in rat mesangial cells and isolated glomeruli. Kidney Int 47:500-509.
36. Shibata T, Yamada T, Ishii T, Kumazawa S, Nakamura H, Masutani H, Yodoi J, and Uchida K (2003) Thioredoxin as a molecular target of cyclopentenone prostaglandins. J Biol Chem 278:26046-26054.
37. Straus DS and Glass CK (2001) Cyclopentenone prostaglandins: new insights on biological activities and cellular targets. Med Res Rev 21:185-210.
38. Straus DS, Pascual G, Li M, Welch JS, Ricote M, Hsiang CH, Sengchanthalangsy LL, Ghosh G, and Glass CK (2000) 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proc Natl Acad Sci USA 87:4844-4849.
39. 2 on cytokine signaling in pancreatic beta-cells. Am J Physiol 286:E329-E336.
40. 2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J Immunol 171:6827-6837.